Public Affairs – fostering knowledge transfer between industry and public stakeholders

Our public affairs team aspires to be a leader in responsibility and transparency in the public policy process regarding medicinal cannabis and the cannabis legalization for adult-use.

We are committed to open and transparent discussions that advance the discourse on facts, create a safe and better future for our partners, customers and patients in order to promote trust in the European cannabis industry.

We are proud member of key associations within the cannabis industry, furthering our commitment to excellence and collaboration. As a board member (“Vorstandsmitglied”) of the BPC (Federal Association of Pharmaceutical Cannabinoid Companies), we actively contribute to shaping the voice of pharmaceutical cannabinoid companies in Germany. Furthermore, as a supporting member (“Fördermitglied”) of the VCA (Association of Cannabis Supplying Pharmacies e.V.), we are at the forefront of ensuring quality cannabis care through pharmacies. These partnerships underscore our dedication to leading the industry forward with integrity and expertise.

In addition to our focus on ethical business practices, we prioritize compliance with all relevant laws and regulations in the industry, including registering our lobbying activities and working in accordance with state code of conduct.

Find our latest publications and political letters here.

Press contact

pr@cansativa.de

⸻ Presse

Media Kit, Logos &
Photos

⸻ Media

Media Kit

PDF file (3.2 MB)

Logos & Images

ZIP file (47.5 MB)

Press
notices

Keep up to date with the latest news from Cansativa – from product launches and successes to our latest positions on current developments.

Publications
⸻ Veröffentlichungen

Company presentation
to download

⸻ Downloads

UP 2024

PDF-Datei (2,3 MB)

Read
our cannabis
Briefing.

Stay up to date on the latest developments in medical cannabis and the legalization process for adult recreational use.

Cannabis briefing
⸻ Briefing

Position papers
& Publications

⸻ Dokumente

Our position papers address many of the most important issues in our business area. They transparently explain our company position and current assessment on specific topics

Q1 2024 I Politikbrief

PDF file (571 KB)

Q3 2023 I Policy letter

PDF file (383 KB)


Q1 2023 | Policy Brief

PDF file (165 KB)


Q4 2022 | Position paper

PDF file (188 KB)

Opinion on the draft bill (CanG-E)

PDF file (834 KB)


Regulation of advertising

PDF file (144 KB)


Econom. Aspects of legalization

PDF file (155 KB)

Known from

Explore Our Cannabis Briefing

Stay ahead with the latest insights in medical cannabis, political decisions, industry news, and research advances.

⸻ Newsletter

Stay informed!

Our newsletter is designed to keep you informed and ahead in the rapidly evolving world of medical cannabis. The Cannabis Briefing is your essential resource for the latest research findings, regulatory updates, market trends, and advocacy efforts shaping the future of cannabis.